The challenge
Wounds of different etiologies are a challenge for the patient, the health professional and healthcare systems. An adequate treatment right from the start may be essential for the final outcome.
Based on natural processes and physical interactions, Sorbact safely removes bacteria to prevent and treat infection without releasing active agents into the wound. Make a good choice for your patients.
The Sorbact solution
The killing of bacteria means endotoxins are released from dead cells and cell debris is left in the wound. So, unlike antimicrobial dressings that actively kill bacteria, Sorbact removes bacteria, irreversibly binding them to its surface to reduce bioburden and support wound healing.
Area of use
Right from the start. Sorbact for any kind of wound at all stages
Products
Product guide
Sorbact dressings offer a solution for a wide range of wounds at all stages in the wound-healing process, making wound management easy for both caregivers and patients. Make a good choice for your patients. Choose Sorbact.
Evidence
Proven to prevent and treat wound infection
Proven in more than 40 clinical studies and in publications including over 7,000 patients, Sorbact has more than 30 years of successful use in clinical practice. Today Sorbact is helping patients in over 65 countries around the world and we are continuing this important work by collecting clinical data.
Abigo Medical - an Essity company
Abigo Medical is a Swedish life science company founded in 1989. Since 2021, Abigo Medical is owned by the global hygiene and health company Essity and part of Business Area Health and Medical. We are dedicated to improving well-being through leading hygiene and health solutions.
